News Release

U of T research finds glycine could be key to REM Sleep Behavior Disorder

Peer-Reviewed Publication

University of Toronto

TORONTO, ON. – There is new promise on the horizon for those who suffer from REM Sleep Behaviour Disorder (RBD) according to researchers at the University of Toronto.

RDB, a neurological disorder that causes violent twitches and muscle contractions during rapid eye-movement (REM) sleep, can lead to serious injuries. John Peever, Assistant Professor at the University of Toronto, discovered that an inhibitory brain chemical called glycine is responsible for actively suppressing muscle twitches in REM sleep. Deficiency in glycine levels in the brain cells that control muscles (motoneurons) was found to cause the violent muscle contractions that mimic the primary symptom of RBD.

“This study shows the mechanism that suppresses muscles twitches in REM sleep and this will lead to better treatments and potential cures for this disorder,” says Peever. “Treating REM sleep disorder may have much broader implications, since within five to eight years of being diagnosed with this disorder, 60-80% of individuals eventually develop Parkinson’s disease.”

###

The study findings are published in the March 26th edition of the Journal of Neuroscience.

For more information, please contact:

John Peever
Assistant Professor
Department of Physiology & Cell & Systems Biology
Office - 416-946-5564
Cell – 647-207-7920
john.peever@utoronto.ca


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.